Global Api Intermediates Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
USD
2.34 Billion
USD
5.67 Billion
2022
2030
 Período de previsão |
2023 –2030 |
 Tamanho do mercado (ano base ) | USD 2.34 Billion |
 Tamanho do mercado ( Ano de previsão) | USD 5.67 Billion |
 CAGR |
% |
| Principais participantes do mercado |
|
Global API Intermediates Market, By Type (Veterinary Drug Intermediates, Pharmaceutical / Bulk Drug Intermediates), Product (Bromo Compound, O-Benzyl Salbutamol, Hemisulfate, Oxirane, Bisoprolol Base, Chiral PCBHP, Pheniramine Base, Chlorpheniramine Base, Brompheniramine Base, Mepyramine/Pyrilamine Base, 6-Amino-1,3-Dimethyl Uracil, Theofylline, Acefylline, Xanthine, Nitriles, Others), Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology, Others), Customers (Direct Users/Pharma Companies, Traders/Wholesalers/Distributors, Associations/Govt. Institutions/Pvt Institutions), End User (API Manufacturer, Finished Product Manufacturer), Distribution Channel (Direct Tender, Retail Sales, Others) - Industry Trends and Forecast to 2030.
Global API Intermediates Market Analysis and Size
Active pharmaceutical ingredients are the substance or combination of substances intended to be used in the manufacturing of a drug product which when used in the production of the drug, becomes an active pharmaceutical ingredient. Such substances are used to provide pharmacological activity.
Data Bridge Market Research analyses that the global API intermediates market which was USD 2.34 billion in 2022, is expected to reach USD 5.67 billion by 2030, and is expected to undergo a CAGR of 7.10% during the forecast period of 2023-2030. “Pharmaceutical/bulk drug intermediates” dominates the type segment of the global API intermediates market owing to the rising pharmaceutical industries. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
API Intermediates Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2021) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Type (Veterinary Drug Intermediates, Pharmaceutical / Bulk Drug Intermediates), Product (Bromo Compound, O-Benzyl Salbutamol, Hemisulfate, Oxirane, Bisoprolol Base, Chiral PCBHP, Pheniramine Base, Chlorpheniramine Base, Brompheniramine Base, Mepyramine/Pyrilamine Base, 6-Amino-1,3-Dimethyl Uracil, Theofylline, Acefylline, Xanthine, Nitriles, Others), Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology, Others), Customers (Direct Users/Pharma Companies, Traders/Wholesalers/Distributors, Associations/Govt. Institutions/Pvt Institutions), End User (API Manufacturer, Finished Product Manufacturer), Distribution Channel (Direct Tender, Retail Sales, Others) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa |
|
Market Players Covered |
|
|
Market Opportunities |
|
Market Definition
When discussing medicines and chemical synthesis, the term "API intermediates" refers to the many chemical compounds and materials created throughout the lengthy process of synthesising an Active Pharmaceutical Ingredient (API). The active ingredients (APIs) of a medicine are those that give it its therapeutic action. The creation of APIs frequently entails a number of chemical reactions, purification procedures, and conversions of raw ingredients into the desired finished product. Various intermediate compounds are created throughout this process, each acting as a stepping stone towards the final API. These intermediaries might have unique chemical characteristics, structures, and applications.
Global API Intermediates Market Dynamics
Drivers
- Growing Pharmaceutical Industry
Devido a factores como o envelhecimento da população, o aumento dos custos com os cuidados de saúde e a procura de tratamentos novos e criativos, o sector farmacêutico continua a crescer a nível global. Esta expansão alimenta a necessidade de intermediários de API, que são ingredientes cruciais na produção de produtos farmacêuticos.
- Avanços tecnológicos crescentes
A eficiência e a relação custo-benefício do fabrico de intermediários de API são melhoradas pelos desenvolvimentos na síntese química e nas tecnologias de processo, alimentando assim a expansão do mercado.
- Aumento da procura por biofármacos
A necessidade de intermediários de bioprocessos aumentou como resultado do aumento de produtos biofarmacêuticos, como proteínas recombinantes e anticorpos monoclonais . Estas etapas do processo são necessárias para produzir produtos biológicos , o que está a ajudar a impulsionar o crescimento do mercado.
Oportunidades
- Crescente procura por medicina personalizada
O desenvolvimento de APIs e intermediários personalizados para perfis específicos de doentes é exigido pela tendência da medicina personalizada e dos medicamentos direcionados, o que pode estimular a investigação e o desenvolvimento neste campo.
- Aumento da colaboração e das parcerias
Soluções inovadoras e acesso a novos mercados podem resultar da colaboração entre produtores intermediários de API, empresas farmacêuticas e organizações de investigação.
- Foco crescente em direção à química verde e sustentável
Existe uma hipótese de os produtores de intermediários de API criarem e fornecerem processos e intermediários químicos mais ecológicos e sustentáveis, à medida que a sustentabilidade e as práticas amigas do ambiente recebem cada vez mais atenção.
Restrições/Desafios
- Regulamentos rigorosos
No setor farmacêutico, as regulamentações regulamentares rigorosas podem ser uma grande barreira. Pode ser dispendioso e demorado cumprir e acompanhar regras como as Boas Práticas de Fabrico (BPF) e limitar o crescimento do mercado.
- Interrupções na cadeia de abastecimento
Devido ao facto de muitos fabricantes dependerem de uma rede global complexa de fornecedores para as suas matérias-primas e intermediários, o mercado global de intermediários de API é vulnerável a perturbações na cadeia de abastecimento. A cadeia de abastecimento pode ser prejudicada por circunstâncias imprevistas, como desastres naturais ou agitação política.
- Preocupações com a segurança
Uma das principais prioridades é garantir a segurança dos procedimentos industriais e a segurança dos colaboradores. Substâncias e reações perigosas podem ser utilizadas no processo de síntese química.
- Custos elevados
A relação custo-benefício e a estabilidade da cadeia de abastecimento do fabrico de intermediários de API podem ser afetadas por alterações nos preços e na disponibilidade de matérias-primas e produtos químicos.
Este relatório do mercado global de intermediários de API fornece detalhes de novos desenvolvimentos recentes, regulamentos comerciais, análise de importação e exportação, análise de produção, otimização da cadeia de valor, quota de mercado, impacto dos participantes do mercado doméstico e localizado, analisa oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações do mercado, análise estratégica do crescimento do mercado, tamanho do mercado, crescimento do mercado das categorias, nichos de aplicação e dominância, aprovações de produtos, lançamentos de produtos, expansões geográficas, inovações tecnológicas no mercado. Para mais informações sobre o mercado global de intermediários de API, contacte a Data Bridge Market Research para obter um briefing de analista.
Âmbito do mercado global de intermediários de API
O mercado global de intermediários de API está segmentado com base no tipo, produto, classe terapêutica, clientes, utilizadores finais e canal de distribuição. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.
Tipo
- Intermediários de Medicamentos Veterinários
- Intermediários farmacêuticos/medicamentos a granel
Produto
- Composto de Bromo
- O-Benzil Salbutamol
- Hemissulfato
- Oxirano
- Base de bisoprolol
- PCBHP quiral
- Base de Feniramina
- Base de Clorfeniramina
- Base de bromfeniramina
- Base de mepiramina/pirilamina
- 6-Amino-1,3-Dimetil Uracilo
- Teofilina
- Acefilina
- Xantina
- Nitrilos
- Outros
Tipo terapêutico
- Doenças autoimunes
- Oncologia
- Doenças Metabólicas
- Oftalmologia
- Doenças cardiovasculares
- Doenças Infecciosas
- Neurologia
- Distúrbios respiratórios
- Dermatologia
- Urologia
- Outros
Clientes
- Utentes diretos/Empresas farmacêuticas
- Comerciantes/Grossistas/Distribuidores
- Associações/Governo. Instituições/Instituições Pvt
Utilizadores finais
- Fabricante de API
- Fabricante de produtos acabados
Canal de distribuição
- Licitação Direta
- Vendas no retalho
- Outros
Análise/Insights Regionais do Mercado Global de Intermediários API
O mercado global de intermediários de API é analisado e são fornecidas informações sobre o tamanho do mercado com base no país, tipo, produto, tipo terapêutico, clientes, utilizador final e canal de distribuição, conforme referenciado acima.
Os países abrangidos pelo relatório do mercado global de intermediários de API são os EUA, Canadá, México, Alemanha, Reino Unido, França, Itália, Espanha, Países Baixos, Rússia, Suíça, Turquia, Áustria, Noruega, Hungria, Lituânia, Irlanda, Polónia , resto do Europa, Japão, China, Austrália, Índia, Coreia do Sul, Singapura, Indonésia, Tailândia, Malásia, Filipinas, Vietname, resto da Ásia-Pacífico, Brasil, Argentina, Peru, resto da América do Sul, Arábia Saudita, África do Sul, Emirados Árabes Unidos, Israel, Kuwait, Egipto e resto do Médio Oriente e África.
A América do Norte domina o mercado global de intermediários de API e prevê-se que cresça com a maior taxa de crescimento no período previsto de 2023 a 2030 devido ao aumento dos gastos em saúde e à infraestrutura de saúde bem estabelecida para o segmento de intermediários farmacêuticos/medicamentos a granel.
A região Ásia-Pacífico está a liderar o crescimento do mercado global de intermediários de API e o segmento de intermediários farmacêuticos/medicamentos a granel está a dominar o país devido ao aumento da disponibilidade de intermediários de API a custos mais baixos. O segmento de intermediários farmacêuticos/medicamentos a granel na Alemanha está a dominar o mercado global de intermediários de IFA devido à crescente procura de consumo de intermediários de IFA.
A secção do relatório sobre os países também fornece fatores individuais que impactam o mercado e alterações na regulamentação do mercado nacional que impactam as tendências atuais e futuras do mercado. Pontos de dados como novas vendas, vendas de reposição, demografia do país, atos regulamentares e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, a presença e a disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, bem como o impacto dos canais de vendas, são considerados ao fornecer uma análise de previsão dos dados do país.
Crescimento da base instalada da infraestrutura de saúde e penetração de novas tecnologias
O mercado global de intermediários de API também fornece análises de mercado detalhadas para análise de doentes, prognóstico e curas. Prevalência, incidência, mortalidade e taxas de adesão são algumas das variáveis de dados disponíveis no relatório. As análises de impacto direto ou indireto da epidemiologia no crescimento do mercado são analisadas para criar um modelo estatístico multivariado de coorte mais robusto para prever o mercado no período de crescimento de 2023-2030.
Análise do cenário competitivo e da quota de mercado dos intermediários de API
O panorama competitivo do mercado global de intermediários de API fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, pipelines de testes de produto, aprovações de produto, patentes, largura e amplitude do produto, domínio da aplicação, curva de vida da tecnologia. Os pontos de dados fornecidos acima estão apenas relacionados com o foco da empresa no mercado global de intermediários de API.
Alguns dos principais participantes que operam no mercado global de intermediários de API são:
- HIKAL Ltd. (Índia)
- Cambrex Corporation (EUA)
- Ganesh-Group, AlzChem Group AG (Índia)
- Vasudha Pharma (Índia)
- Empresa: Anyang General Chemical Co., Ltd. (China)
- Sarex (Índia)
- Sandoo Pharmaceuticals and Chemicals Co., Ltd (Índia)
- Atul Ltd (Índia)
- Sandoz International GmbH (uma subsidiária da Novartis AG) (Alemanha)
- Aceto (EUA)
- Supriya Lifescience Ltd. (Índia)
- LEVACHEM COMPANY LIMITED (China)
- Vertellus (EUA)
- Dishman Carbonogen Amcis Ltd (Índia)
- Sanofi (França)
- Divi's Laboratories Limited (Índia)
- AARTI INDUSTRIES LIMITED (Índia)
- Aurobindo Pharma (Índia)
- BASF SE (Alemanha)
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of GLOBAL API intermediates MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- MARKET type COVERAGE GRID
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insight
- CURRENT SCENARIO OF IMPORT AND EXPORT OF API INTERMEDIATE
- Tentative Production and operational costs calculations which will ultimately lead to feasibility of the product manufacturing
- Tentative Land requirement for a Substantial Production Capacity Plant Set-Up
- GLOBAL API INTERMEDIATES MARKET: 3C ANALYSIS-CHINA EFFECT
- THE U.S.-CHINA TRADE WAR
- INDO-CHINA GEOPOLITICAL ISSUES
- CHINESE SLOWDOWN DUE TO E&C OVER THE YEARS
- CHINESE SLOWDOWN DUE TO COVID-19 (CORONAVIRUS)
- Cost Analysis
- Analysis on China API intermediates:
- Conclusion:
- porters five forces model
- Pestel analysis
- global API INTERMEDIATES market: regulatORY
- THE U.S. REGULATORY GUIDANCE FOR NON-CLINICAL SAFETY EVALUATION OF API INTERMEDIATES
- CANADA REGULATORY GUIDANCE FOR API INTERMEDIATES
- EUROPE REGULATORY SCENARIO FOR API INTERMEDIATES
- JAPAN REGULATORY FOR API INTERMEDIATES
- MIDDLE EAST AND AFRICA REGULATORY FRAMEWORK FOR API INTERMEDIATES
- GLOBAL API INTERMEDIATES MARKET: CONCLUSION
- TOP PRODUCTS AND THERAPEUTIC AREAS
- ADDITIONAL
- CUSTOMER SENTIMENTS/INCLINATION TOWARDS FINDING ALTERNATE VENDOR SOURCE
- LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE:
- Market Overview
- Drivers
- HIGH BURDEN OF CHRONIC DISEASES
- increase in aging population
- utilization of advanceD technology in active pharmaceutical ingredients (api) manufacturing
- increasing disease awareness and education
- research and development regarding pharmaceutical API and their intermediates
- restrainTs
- availability of sub-standard and counterfeit drugs
- product recalls
- high manufacturing cost
- stringent government regulations for api intermediates
- opportunities
- strategic initiatives by the market players
- increasing healthcare expenditure
- SOARING NUMBER OF API INTERMEDIATES MANUFACTURERS
- RISE IN NUMBER OF CONTRACT MANUFACTURING ORGANIZATIONS (CMO) AND CONTRACT RESEARCH ORGANIZATIONS (crO)
- challenges
- disruption in the supply chain of active pharmaceutical ingredients (api) during covid-19
- lack of workforce in pharma industries
- Impact of COVID 19 on Global API Intermediates market
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY CHAIIN
- STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
- CONCLUSION
- global API intermediates MARKET, BY type
- overview
- pharmaceutical intermediates/ bulk drug intermediates
- Veterinary Drug Intermediates
- global API intermediates MARKET, BY product
- overview
- Nitriles
- bromo compound
- Chiral PCBHP
- Chlorpheniramine Base
- Brompheniramine Base
- Pheniramine Base
- O-Benzyl Salbutamol
- Bisoprolol Base
- Hemisulfate
- Oxirane
- Mepyramine/Pyrilamine Base
- Theofylline
- Acefylline
- Xanthine
- 6-Amino-1,3-Dimethyl Uracil
- others
- global API intermediates MARKET, BY therapeutic type
- overview
- Cardiovascular Diseases
- Metabolic Diseases
- infectious Diseases
- respiratory Diseases
- neurology
- oncology
- Autoimmune Disease
- Dermatology
- ophthalmology
- urology
- others
- global API intermediates MARKET, BY customers
- overview
- Direct Users/Pharma Companies
- Traders/Wholesalers/Distributors
- Associations/Govt. Institutions/Pvt Institutions
- global API intermediates MARKET, BY End User
- overview
- API manufacturer
- finished product manufacturer
- global API intermediates MARKET, BY distribution channel
- overview
- direct tender
- Retail Sale
- others
- Global API Intermediates Market by geography
- Overview
- NORTH AMERICA
- U.S
- CANADA
- MEXICO
- EUROPE
- GERMANY
- U.K
- ITALY
- SPAIN
- FRANCE
- NETHERLANDS
- RUSSIA
- SWITZERLAND
- TURKEY
- AUSTRIA
- NORWAY
- HUNGARY
- LITHUANIA
- IRELAND
- POLAND
- REST OF ASIA PACIFIC
- ASIA-PACIFIC
- CHINA
- INDIA
- JAPAN
- AUSTRALIA
- SOUTH KOREA
- SINGAPORE
- MALAYSIA
- THAILAND
- INDONESIA
- PHILIPPINES
- VIETNAM
- REST OF ASIA PACIFIC
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- PERU
- REST OF SOUTH AMERICA
- MIDDLE EAST & AFRICA
- SAUDI ARABIA
- SOUTH AFRICA
- UAE
- ISRAEL
- KUWAIT
- EGYPT
- REST OF MIDDLE EAST & AFRICA
- Global API Intermediates Market: COMPANY landscape
- company share analysis: global
- company share analysis: north america
- company share analysis: europe
- company share analysis: Asia-Pacific
- swot analysis
- company profile
- aurobindo pharma
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORFOLIO
- RECENT DEVELOPMENTS
- Divi’s laboratories limited
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- basf se
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- CAMBRIX CORPORATION
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Sandoz International GmbH (a subsidiary of Novartis AG)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- aceto
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- hikal ltd.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- alzchem group ag
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- vertellus
- COMPANY SNAPSHOT
- PRODUCT CATEGORIES
- RECENT DEVELOPMENTS
- sanofi
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORFOLIO
- RECENT DEVELOPMENTS
- atul ltd
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- aarti industries limited
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- vasudha pharma
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- anyang general chemical co., Ltd.
- COMPANY SNAPSHOT
- PRODUCT PORFOLIO
- RECENT DEVELOPMENT
- dishman carbogen amics ltd
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORFOLIO
- RECENT DEVELOPMENTS
- ganesh-group
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- levachem company limited
- COMPANY SNAPSHOT
- PRODUCT PORFOLIO
- RECENT DEVELOPMENT
- sandoo pharmaceuticals and chemicals co., ltd.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- sarex
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- SUPRIYA LIFESCIENCE LTD.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- questionnaire
- related reports
Lista de Tabela
TABLE 1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: CUSTOMIZATION (COUNTRIES INVOLVED IN IMPORT & EXPORT)
TABLE 2 Percentage Break up of Cost
TABLE 3 Tentative Land Requirement
TABLE 4 Percentage Break up of Plant Area
TABLE 5 Table: 1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE
TABLE 6 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
TABLE 7 MARKET PLAYERS OF API INTERMEDIATES
TABLE 8 Sales Data of API intermediates for 2019/2020
TABLE 9 Global API intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 10 Global pharmaceutical intermediates/ bulk drug intermediates in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 11 Global Veterinary Drug Intermediates in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 12 Global API intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 13 Global nitriles in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 14 Global bromo compound in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 15 Global chiral PCBHP in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 16 Global chlorpheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 17 Global brompheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 18 Global pheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 19 Global O-Benzyl Salbutamol in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 20 Global bisoprolol base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 21 Global hemisulfate in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 22 Global oxirane in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 23 Global mepyramine/pyrilamine base in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 24 Global theofylline in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 25 Global acefylline in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 26 Global Xanthine in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 27 Global 6-amino-1, 3-dimethyl uracil in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 28 Global others in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 29 Global API intermediates Market, By THERAPEUTIC Type, 2019-2028 (USD Million)
TABLE 30 globaL cardiovascular diseases in API intermediates Market, By Region, 2017-2028 (USD Million)
TABLE 31 globaL metabolic diseases in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 32 globaLinfectious diseases in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 33 globaL respiratory diseases in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 34 globaL neurology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 35 globaL oncology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 36 globaL autoimmune diseases in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 37 globaL dermatology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 38 globaL ophthalmology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 39 globaL urology in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 40 globaL others in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 41 Global API intermediates Market, By CUSTOMERS, 2019-2028 (USD Million)
TABLE 42 globaL Direct Users/Pharma Companies in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 43 globaL Traders/Wholesalers/Distributors in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 44 globaL Associations/Govt. Institutions/Pvt Institutionsin API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 45 Global API intermediates Market, By END USER, 2019-2028 (USD Million)
TABLE 46 Global API manufacturer in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 47 Global finished product manufacturer in API intermediates Market, By region, 2019-2028 (USD Million)
TABLE 48 Global API intermediates Market, By distribution channel, 2019-2028 (USD Million)
TABLE 49 globaL direct tender in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 50 globaL retail sales in API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 51 globaL Othersin API intermediates Market, By Region, 2019-2028 (USD Million)
TABLE 52 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS MARKET, BY REGION , 2021-2028 (USD MILLION)
TABLE 53 NORTH AMERICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)
TABLE 54 North America API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 55 North America API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 56 North America API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 57 North America API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 58 North America API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 59 North America API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 60 U.S API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 61 U.S API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 62 U.S API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 63 U.S API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 64 U.S API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 65 U.S API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 66 Canada API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 67 Canada API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 68 Canada API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 69 Canada API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 70 Canada API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 71 Canada API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 72 MEXICO API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 73 MEXICO API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 74 MEXICO API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 75 MEXICO API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 76 MEXICO API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 77 MEXICO API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 78 Europe API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 79 Europe API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 80 Europe API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 81 Europe API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 82 Europe API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 83 Europe API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 84 Europe API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 85 Germany API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 86 Germany API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 87 Germany API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 88 Germany API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 89 Germany API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 90 Germany API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 91 U.K API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 92 U.K API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 93 U.K API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 94 U.K API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 95 U.K API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 96 U.K API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 97 U.K API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 98 Italy API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 99 Italy API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 100 Italy API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 101 Italy API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 102 Italy API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 103 Spain API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 104 Spain API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 105 Spain API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 106 Spain API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 107 Spain API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 108 Spain API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 109 France API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 110 France API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 111 France API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 112 France API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 113 France API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 114 France API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 115 Netherlands API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 116 Netherlands API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 117 Netherlands API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 118 Netherlands API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 119 Netherlands API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 120 Netherlands API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 121 Russia API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 122 Russia API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 123 Russia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 124 Russia API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 125 Russia API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 126 Russia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 127 Switzerland API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 128 Switzerland API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 129 Switzerland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 130 Switzerland API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 131 Switzerland API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 132 Switzerland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 133 Turkey API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 134 Turkey API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 135 Turkey API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 136 Turkey API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 137 Turkey API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 138 Turkey API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 139 Austria API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 140 Austria API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 141 Austria API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 142 Austria API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 143 Austria API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 144 Austria API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 145 Norway API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 146 Norway API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 147 Norway API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 148 Norway API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 149 Norway API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 150 Norway API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 151 Hungary API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 152 Hungary API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 153 Hungary API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 154 Hungary API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 155 Hungary API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 156 Hungary API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 157 Lithuania API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 158 Lithuania API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 159 Lithuania API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 160 Lithuania API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 161 Lithuania API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 162 Lithuania API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 163 Ireland API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 164 Ireland API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 165 Ireland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 166 Ireland API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 167 Ireland API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 168 Ireland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 169 Poland API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 170 Poland API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 171 Poland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 172 Poland API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 173 Poland API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 174 Poland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 175 Rest of Asia Pacific API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 176 ASIA-PACIFIC API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)
TABLE 177 Asia-Pacific API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 178 Asia-Pacific API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 179 Asia-Pacific API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 180 Asia-Pacific API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 181 Asia-Pacific API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 182 Asia-Pacific API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 183 China API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 184 China API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 185 China API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 186 China API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 187 China API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 188 China API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 189 India API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 190 India API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 191 India API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 192 India API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 193 India API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 194 India API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 195 India API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 196 Japan API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 197 Japan API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 198 Japan API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 199 Japan API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 200 Japan API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 201 australia API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 202 Australia API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 203 Australia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 204 Australia API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 205 Australia API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 206 Australia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 207 South Korea API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 208 South Korea API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 209 South Korea API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 210 South Korea API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 211 South Korea API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 212 South Korea API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 213 Singapore API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 214 Singapore API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 215 Singapore API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 216 Singapore API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 217 Singapore API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 218 Singapore API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 219 Malaysia API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 220 Malaysia API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 221 Malaysia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 222 Malaysia API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 223 Malaysia API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 224 Malaysia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 225 Thailand API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 226 Thailand API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 227 Thailand API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 228 Thailand API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 229 Thailand API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 230 Thailand API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 231 Indonesia API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 232 Indonesia API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 233 Indonesia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 234 Indonesia API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 235 Indonesia API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 236 Indonesia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 237 Philippines API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 238 Philippines API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 239 Philippines API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 240 Philippines API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 241 Philippines API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 242 Philippines API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 243 Vietnam API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 244 Vietnam API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 245 Vietnam API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 246 Vietnam API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 247 Vietnam API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 248 Vietnam API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 249 Rest of Asia Pacific API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 250 SOUTH AMERICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)
TABLE 251 South America API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 252 South America API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 253 South America API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 254 South America API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 255 South America API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 256 South America API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 257 BRAZIL API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 258 BRAZIL API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 259 BRAZIL API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 260 BRAZIL API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 261 BRAZIL API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 262 BRAZIL API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 263 Argentina API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 264 Argentina API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 265 Argentina API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 266 Argentina API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 267 Argentina API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 268 Argentina API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 269 PERU API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 270 PERU API intermediates market, By Product, 2019-2028 (USD Million)
TABLE 271 PERU API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 272 PERU API intermediates market, By Customers, 2019-2028 (USD Million)
TABLE 273 PERU API intermediates market, By End User, 2019-2028 (USD Million)
TABLE 274 PERU API intermediates market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 275 Rest of South America API intermediates market, By Type, 2019-2028 (USD Million)
TABLE 276 MIDDLE EAST & AFRICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)
TABLE 277 Middle East & Africa API Intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 278 Middle East & Africa API Intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 279 Middle East & Africa API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 280 Middle East & Africa API Intermediates Market, By Customers, 2019-2028 (USD Million)
TABLE 281 Middle East & Africa API Intermediates Market, By End User, 2019-2028 (USD Million)
TABLE 282 Middle East & Africa API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 283 Saudi Arabia API Intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 284 Saudi Arabia API Intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 285 Saudi Arabia API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 286 Saudi Arabia API Intermediates Market, By Customers, 2019-2028 (USD Million)
TABLE 287 Saudi Arabia API Intermediates Market, By End User, 2019-2028 (USD Million)
TABLE 288 Saudi Arabia API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 289 South Africa API Intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 290 South Africa API Intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 291 South Africa API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 292 South Africa API Intermediates Market, By Customers, 2019-2028 (USD Million)
TABLE 293 South Africa API Intermediates Market, By End User, 2019-2028 (USD Million)
TABLE 294 South Africa API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 295 UAE API Intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 296 UAE API Intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 297 UAE API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 298 UAE API Intermediates Market, By Customers, 2019-2028 (USD Million)
TABLE 299 UAE API Intermediates Market, By End User, 2019-2028 (USD Million)
TABLE 300 UAE API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 301 Israel API Intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 302 Israel API Intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 303 Israel API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 304 Israel API Intermediates Market, By Customers, 2019-2028 (USD Million)
TABLE 305 Israel API Intermediates Market, By End User, 2019-2028 (USD Million)
TABLE 306 Israel API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 307 Kuwait API Intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 308 Kuwait API Intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 309 Kuwait API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 310 Kuwait API Intermediates Market, By Customers, 2019-2028 (USD Million)
TABLE 311 Kuwait API Intermediates Market, By End User, 2019-2028 (USD Million)
TABLE 312 Kuwait API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 313 Egypt API Intermediates Market, By Type, 2019-2028 (USD Million)
TABLE 314 Egypt API Intermediates Market, By Product, 2019-2028 (USD Million)
TABLE 315 Egypt API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)
TABLE 316 Egypt API Intermediates Market, By Customers, 2019-2028 (USD Million)
TABLE 317 Egypt API Intermediates Market, By End User, 2019-2028 (USD Million)
TABLE 318 Egypt API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 319 Rest of Middle East & Africa API Intermediates Market, By Type, 2019-2028 (USD Million)
Lista de Figura
FIGURE 1 Global API INTERMEDIATES MARKET: SEGMENTATION
FIGURE 2 GLOBAL API INTERMEDIATES MARKET: DATA TRIANGULATION
FIGURE 3 global API intermediates Market: DROC ANALYSIS
FIGURE 4 Global API intermediates market: Global VS REGIONAL MARKET ANALYSIS
FIGURE 5 Global API intermediates Market: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL API intermediates MARKET: MULTIVARIATE MODELLING
FIGURE 7 GLOBAL API intermediates MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 GLOBAL API INTERMEDIATES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL API INTERMEDIATES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL API intermediates MARKET: MARKET type COVERAGE GRID
FIGURE 11 Global API intermediates market: SEGMENTATION
FIGURE 12 NORTH AMERICA is expected to DOMINATE THE GLOBAL API intermediates market AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 north america is the fastest growing market FOR the API intermediates MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 Utilization of advanceD technology in active pharmaceutical ingredients (API) manufacturing is DRIVing THE global API intermediates MARKET IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 15 pharmaceutical / bulk drug intermediates SEGMENT is expected to account for the largest share of the global API INTERMEDIATES MARKET in 2021 & 2028
FIGURE 16 DRIVERS, RESTRAINTs, OPPORTUNITies AND CHALLENGEs OF Global API Intermediates market
FIGURE 17 TOP 5 COUNTRIES FOR NUMBER OF PEOPLE AGED 20 TO 79 SUFFERING FROM DIABETES in 2019
FIGURE 18 ESTIMATED NUMBER OF DIFFERENT TYPEs OF CANCERS IN FEMALE POPULATION in 2020
FIGURE 19 ESTIMATED NUMBER OF DIFFERENT TYPEs OF CANCERS IN MALE POPULATION in 2020
FIGURE 20 10 GLOBAL CAUSES OF DEATHs WITH THE CHRONIC DISEASES
FIGURE 21 NUMBER OF PERSON AGED 60 YEARS OR OVER BY REGIONS in 2020 (IN MILLIONS)
FIGURE 22 MARKET GROWTH IN CLINICAL CRO (IN USD MILLIONS)
FIGURE 23 global API intermediates market: BY type, 2021
FIGURE 24 global API intermediates market: BY type, 2019-2028 (USD Million)
FIGURE 25 global API intermediates market: BY type, CAGR (2021-2028)
FIGURE 26 global API intermediates market: BY type, LIFELINE CURVE
FIGURE 27 global API intermediates market: BY product, 2021
FIGURE 28 global API intermediates market: BY product, 2019-2028 (USD Million)
FIGURE 29 global API intermediates market: BY product, CAGR(2021-2028)
FIGURE 30 global API intermediates market: BY product, LIFELINE CURVE
FIGURE 31 global API intermediates market: BY therapeutic type, 2021
FIGURE 32 global API intermediates market: BY therapeutic type, 2019-2028 (USD Million)
FIGURE 33 global API intermediates market: BY therapeutic type, CAGR (2021-2028)
FIGURE 34 global API intermediates market: BY therapeutic type, LIFELINE CURVE
FIGURE 35 global API intermediates market: BY customers, 2021
FIGURE 36 global API intermediates market: BY customers, 2019-2028 (USD Million)
FIGURE 37 global API intermediates market: BY customers, CAGR (2021-2028)
FIGURE 38 global API intermediates market: BY customers, LIFELINE CURVE
FIGURE 39 global API intermediates market: BY end user, 2021
FIGURE 40 global API intermediates market: BY end user, 2019-2028 (USD Million)
FIGURE 41 global API intermediates market: BY end user, CAGR (2021-2028)
FIGURE 42 global API intermediates market: BY end user, LIFELINE CURVE
FIGURE 43 global API intermediates market: BY distribution channel, 2021
FIGURE 44 global API intermediates market: BY distribution channel, 2019-2028 (USD Million)
FIGURE 45 global API intermediates market: BY distribution channel, CAGR (2021-2028)
FIGURE 46 global API intermediates market: BY distribution channel, LIFELINE CURVE
FIGURE 47 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: SNAPSHOT (2020)
FIGURE 48 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2020)
FIGURE 49 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2021 & 2028)
FIGURE 50 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2020 & 2028)
FIGURE 51 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY type (2021-2028)
FIGURE 52 North America API Intermediates market: SNAPSHOT (2020)
FIGURE 53 North America API Intermediates market: BY COUNTRY (2020)
FIGURE 54 North America API Intermediates market: BY COUNTRY (2021 & 2028)
FIGURE 55 North America API Intermediates market: BY COUNTRY (2020 & 2028)
FIGURE 56 North America API Intermediates market: BY type (2021-2028)
FIGURE 57 Europe API Intermediates market: SNAPSHOT (2020)
FIGURE 58 Europe API INTERMEDIATEs market: BY COUNTRY (2020)
FIGURE 59 Europe API INTERMEDIATEs market: BY COUNTRY (2021 & 2028)
FIGURE 60 Europe API Intermediates market: BY COUNTRY (2020 & 2028)
FIGURE 61 Europe API Intermediates market: BY type (2021-2028)
FIGURE 62 Asia-Pacific API Intermediates market: SNAPSHOT (2020)
FIGURE 63 Asia-Pacific API Intermediates market: BY COUNTRY (2020)
FIGURE 64 Asia-Pacific API Intermediates market: BY COUNTRY (2021 & 2028)
FIGURE 65 Asia-Pacific API Intermediates market: BY COUNTRY (2020 & 2028)
FIGURE 66 Asia-Pacific API Intermediates market: BY type (2021-2028)
FIGURE 67 South America API Intermediates market: SNAPSHOT (2020)
FIGURE 68 South America API Intermediates market: BY COUNTRY (2020)
FIGURE 69 South America API Intermediates market: BY COUNTRY (2021 & 2028)
FIGURE 70 South America API Intermediates market: BY COUNTRY (2020 & 2028)
FIGURE 71 South America API Intermediates market: BY type (2021-2028)
FIGURE 72 Middle East & Africa API Intermediates market: SNAPSHOT (2020)
FIGURE 73 Middle East & Africa API Intermediates market: BY COUNTRY (2020)
FIGURE 74 Middle East & Africa API Intermediates market: BY COUNTRY (2021 & 2028)
FIGURE 75 Middle East & Africa API Intermediates market: BY COUNTRY (2020 & 2028)
FIGURE 76 Middle East & Africa API Intermediates market: BY type (2021-2028)
FIGURE 77 Global API Intermediates market: company share 2020 (%)
FIGURE 78 North America API Intermediates Market: company share 2020 (%)
FIGURE 79 EUROPE API Intermediates Market: company share 2020 (%)
FIGURE 80 ASIA-PACIFIC API Intermediates Market: company share 2020 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
